WO2001055327A8 - Acides nucleiques, proteines et anticorps - Google Patents
Acides nucleiques, proteines et anticorpsInfo
- Publication number
- WO2001055327A8 WO2001055327A8 PCT/US2001/001352 US0101352W WO0155327A8 WO 2001055327 A8 WO2001055327 A8 WO 2001055327A8 US 0101352 W US0101352 W US 0101352W WO 0155327 A8 WO0155327 A8 WO 0155327A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pancreatic
- polypeptides
- polynucleotides
- methods
- further relates
- Prior art date
Links
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 108091005461 Nucleic proteins Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 102000040430 polynucleotide Human genes 0.000 abstract 4
- 108091033319 polynucleotide Proteins 0.000 abstract 4
- 239000002157 polynucleotide Substances 0.000 abstract 4
- 206010061902 Pancreatic neoplasm Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 abstract 3
- 201000002528 pancreatic cancer Diseases 0.000 abstract 3
- 208000008443 pancreatic carcinoma Diseases 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 210000000496 pancreas Anatomy 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 206010027476 Metastases Diseases 0.000 abstract 1
- 102000018886 Pancreatic Polypeptide Human genes 0.000 abstract 1
- 101000983124 Sus scrofa Pancreatic prohormone precursor Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 238000010189 synthetic method Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01912662A EP1255767A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
Applications Claiming Priority (235)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17906500P | 2000-01-31 | 2000-01-31 | |
US60/179,065 | 2000-01-31 | ||
US18062800P | 2000-02-04 | 2000-02-04 | |
US60/180,628 | 2000-02-04 | ||
US18466400P | 2000-02-24 | 2000-02-24 | |
US60/184,664 | 2000-02-24 | ||
US18635000P | 2000-03-02 | 2000-03-02 | |
US60/186,350 | 2000-03-02 | ||
US18987400P | 2000-03-16 | 2000-03-16 | |
US60/189,874 | 2000-03-16 | ||
US19007600P | 2000-03-17 | 2000-03-17 | |
US60/190,076 | 2000-03-17 | ||
US19812300P | 2000-04-18 | 2000-04-18 | |
US60/198,123 | 2000-04-18 | ||
US20551500P | 2000-05-19 | 2000-05-19 | |
US60/205,515 | 2000-05-19 | ||
US20946700P | 2000-06-07 | 2000-06-07 | |
US60/209,467 | 2000-06-07 | ||
US21488600P | 2000-06-28 | 2000-06-28 | |
US60/214,886 | 2000-06-28 | ||
US21513500P | 2000-06-30 | 2000-06-30 | |
US60/215,135 | 2000-06-30 | ||
US21664700P | 2000-07-07 | 2000-07-07 | |
US21688000P | 2000-07-07 | 2000-07-07 | |
US60/216,880 | 2000-07-07 | ||
US60/216,647 | 2000-07-07 | ||
US21749600P | 2000-07-11 | 2000-07-11 | |
US21748700P | 2000-07-11 | 2000-07-11 | |
US60/217,496 | 2000-07-11 | ||
US60/217,487 | 2000-07-11 | ||
US21829000P | 2000-07-14 | 2000-07-14 | |
US60/218,290 | 2000-07-14 | ||
US22096400P | 2000-07-26 | 2000-07-26 | |
US22096300P | 2000-07-26 | 2000-07-26 | |
US60/220,964 | 2000-07-26 | ||
US60/220,963 | 2000-07-26 | ||
US22521400P | 2000-08-14 | 2000-08-14 | |
US22521300P | 2000-08-14 | 2000-08-14 | |
US22575800P | 2000-08-14 | 2000-08-14 | |
US22526800P | 2000-08-14 | 2000-08-14 | |
US22526600P | 2000-08-14 | 2000-08-14 | |
US22544700P | 2000-08-14 | 2000-08-14 | |
US22575700P | 2000-08-14 | 2000-08-14 | |
US22575900P | 2000-08-14 | 2000-08-14 | |
US22451900P | 2000-08-14 | 2000-08-14 | |
US22451800P | 2000-08-14 | 2000-08-14 | |
US22526700P | 2000-08-14 | 2000-08-14 | |
US22527000P | 2000-08-14 | 2000-08-14 | |
US60/225,757 | 2000-08-14 | ||
US60/225,447 | 2000-08-14 | ||
US60/225,267 | 2000-08-14 | ||
US60/225,266 | 2000-08-14 | ||
US60/225,214 | 2000-08-14 | ||
US60/224,519 | 2000-08-14 | ||
US60/224,518 | 2000-08-14 | ||
US60/225,758 | 2000-08-14 | ||
US60/225,270 | 2000-08-14 | ||
US60/225,213 | 2000-08-14 | ||
US60/225,759 | 2000-08-14 | ||
US60/225,268 | 2000-08-14 | ||
US22627900P | 2000-08-18 | 2000-08-18 | |
US60/226,279 | 2000-08-18 | ||
US22686800P | 2000-08-22 | 2000-08-22 | |
US22718200P | 2000-08-22 | 2000-08-22 | |
US22668100P | 2000-08-22 | 2000-08-22 | |
US60/227,182 | 2000-08-22 | ||
US60/226,868 | 2000-08-22 | ||
US60/226,681 | 2000-08-22 | ||
US22700900P | 2000-08-23 | 2000-08-23 | |
US60/227,009 | 2000-08-23 | ||
US22892400P | 2000-08-30 | 2000-08-30 | |
US60/228,924 | 2000-08-30 | ||
US22928700P | 2000-09-01 | 2000-09-01 | |
US22934300P | 2000-09-01 | 2000-09-01 | |
US22934400P | 2000-09-01 | 2000-09-01 | |
US22934500P | 2000-09-01 | 2000-09-01 | |
US60/229,343 | 2000-09-01 | ||
US60/229,344 | 2000-09-01 | ||
US60/229,345 | 2000-09-01 | ||
US60/229,287 | 2000-09-01 | ||
US22950900P | 2000-09-05 | 2000-09-05 | |
US22951300P | 2000-09-05 | 2000-09-05 | |
US60/229,513 | 2000-09-05 | ||
US60/229,509 | 2000-09-05 | ||
US23043800P | 2000-09-06 | 2000-09-06 | |
US23043700P | 2000-09-06 | 2000-09-06 | |
US60/230,438 | 2000-09-06 | ||
US60/230,437 | 2000-09-06 | ||
US23124200P | 2000-09-08 | 2000-09-08 | |
US23208000P | 2000-09-08 | 2000-09-08 | |
US23124400P | 2000-09-08 | 2000-09-08 | |
US23208100P | 2000-09-08 | 2000-09-08 | |
US23124300P | 2000-09-08 | 2000-09-08 | |
US23141300P | 2000-09-08 | 2000-09-08 | |
US23141400P | 2000-09-08 | 2000-09-08 | |
US60/231,244 | 2000-09-08 | ||
US60/231,242 | 2000-09-08 | ||
US60/232,081 | 2000-09-08 | ||
US60/231,243 | 2000-09-08 | ||
US60/232,080 | 2000-09-08 | ||
US60/231,413 | 2000-09-08 | ||
US60/231,414 | 2000-09-08 | ||
US23196800P | 2000-09-12 | 2000-09-12 | |
US60/231,968 | 2000-09-12 | ||
US23306300P | 2000-09-14 | 2000-09-14 | |
US23240000P | 2000-09-14 | 2000-09-14 | |
US23306400P | 2000-09-14 | 2000-09-14 | |
US23306500P | 2000-09-14 | 2000-09-14 | |
US23240100P | 2000-09-14 | 2000-09-14 | |
US23239800P | 2000-09-14 | 2000-09-14 | |
US23239700P | 2000-09-14 | 2000-09-14 | |
US23239900P | 2000-09-14 | 2000-09-14 | |
US60/233,064 | 2000-09-14 | ||
US60/233,063 | 2000-09-14 | ||
US60/232,399 | 2000-09-14 | ||
US60/232,397 | 2000-09-14 | ||
US60/232,401 | 2000-09-14 | ||
US60/232,400 | 2000-09-14 | ||
US60/233,065 | 2000-09-14 | ||
US60/232,398 | 2000-09-14 | ||
US23427400P | 2000-09-21 | 2000-09-21 | |
US23422300P | 2000-09-21 | 2000-09-21 | |
US60/234,274 | 2000-09-21 | ||
US60/234,223 | 2000-09-21 | ||
US23499700P | 2000-09-25 | 2000-09-25 | |
US23499800P | 2000-09-25 | 2000-09-25 | |
US60/234,997 | 2000-09-25 | ||
US60/234,998 | 2000-09-25 | ||
US23548400P | 2000-09-26 | 2000-09-26 | |
US60/235,484 | 2000-09-26 | ||
US23583400P | 2000-09-27 | 2000-09-27 | |
US23583600P | 2000-09-27 | 2000-09-27 | |
US60/235,834 | 2000-09-27 | ||
US60/235,836 | 2000-09-27 | ||
US23636900P | 2000-09-29 | 2000-09-29 | |
US23636700P | 2000-09-29 | 2000-09-29 | |
US23636800P | 2000-09-29 | 2000-09-29 | |
US23632700P | 2000-09-29 | 2000-09-29 | |
US23637000P | 2000-09-29 | 2000-09-29 | |
US60/236,327 | 2000-09-29 | ||
US60/236,367 | 2000-09-29 | ||
US60/236,368 | 2000-09-29 | ||
US60/236,370 | 2000-09-29 | ||
US60/236,369 | 2000-09-29 | ||
US23703800P | 2000-10-02 | 2000-10-02 | |
US23704000P | 2000-10-02 | 2000-10-02 | |
US23703700P | 2000-10-02 | 2000-10-02 | |
US23703900P | 2000-10-02 | 2000-10-02 | |
US23680200P | 2000-10-02 | 2000-10-02 | |
US60/236,802 | 2000-10-02 | ||
US60/237,039 | 2000-10-02 | ||
US60/237,037 | 2000-10-02 | ||
US60/237,038 | 2000-10-02 | ||
US60/237,040 | 2000-10-02 | ||
US23993500P | 2000-10-13 | 2000-10-13 | |
US23993700P | 2000-10-13 | 2000-10-13 | |
US60/239,935 | 2000-10-13 | ||
US60/239,937 | 2000-10-13 | ||
US24182600P | 2000-10-20 | 2000-10-20 | |
US24122100P | 2000-10-20 | 2000-10-20 | |
US24178500P | 2000-10-20 | 2000-10-20 | |
US24178700P | 2000-10-20 | 2000-10-20 | |
US24180900P | 2000-10-20 | 2000-10-20 | |
US24096000P | 2000-10-20 | 2000-10-20 | |
US24178600P | 2000-10-20 | 2000-10-20 | |
US24180800P | 2000-10-20 | 2000-10-20 | |
US60/241,221 | 2000-10-20 | ||
US60/241,786 | 2000-10-20 | ||
US60/241,809 | 2000-10-20 | ||
US60/241,787 | 2000-10-20 | ||
US60/241,785 | 2000-10-20 | ||
US60/240,960 | 2000-10-20 | ||
US60/241,808 | 2000-10-20 | ||
US60/241,826 | 2000-10-20 | ||
US24461700P | 2000-11-01 | 2000-11-01 | |
US60/244,617 | 2000-11-01 | ||
US24647700P | 2000-11-08 | 2000-11-08 | |
US24661100P | 2000-11-08 | 2000-11-08 | |
US24647400P | 2000-11-08 | 2000-11-08 | |
US24661000P | 2000-11-08 | 2000-11-08 | |
US24653200P | 2000-11-08 | 2000-11-08 | |
US24647600P | 2000-11-08 | 2000-11-08 | |
US24652700P | 2000-11-08 | 2000-11-08 | |
US24652500P | 2000-11-08 | 2000-11-08 | |
US24652800P | 2000-11-08 | 2000-11-08 | |
US24647500P | 2000-11-08 | 2000-11-08 | |
US24652600P | 2000-11-08 | 2000-11-08 | |
US60/246,527 | 2000-11-08 | ||
US60/246,476 | 2000-11-08 | ||
US60/246,523 | 2000-11-08 | ||
US60/246,526 | 2000-11-08 | ||
US60/246,475 | 2000-11-08 | ||
US60/246,613 | 2000-11-08 | ||
US60/246,525 | 2000-11-08 | ||
US60/246,528 | 2000-11-08 | ||
US60/246,524 | 2000-11-08 | ||
US60/246,477 | 2000-11-08 | ||
US60/246,611 | 2000-11-08 | ||
US60/246,474 | 2000-11-08 | ||
US60/246,532 | 2000-11-08 | ||
US60/246,610 | 2000-11-08 | ||
US60/246,478 | 2000-11-08 | ||
US60/246,609 | 2000-11-08 | ||
US60/249,300 | 2000-11-17 | ||
US60/249,297 | 2000-11-17 | ||
US60/249,299 | 2000-11-17 | ||
US60/249,208 | 2000-11-17 | ||
US60/249,210 | 2000-11-17 | ||
US60/249,245 | 2000-11-17 | ||
US60/249,212 | 2000-11-17 | ||
US60/249,264 | 2000-11-17 | ||
US60/249,217 | 2000-11-17 | ||
US60/249,209 | 2000-11-17 | ||
US60/249,265 | 2000-11-17 | ||
US60/249,244 | 2000-11-17 | ||
US60/249,207 | 2000-11-17 | ||
US60/249,211 | 2000-11-17 | ||
US60/249,213 | 2000-11-17 | ||
US60/249,218 | 2000-11-17 | ||
US60/249,216 | 2000-11-17 | ||
US60/249,214 | 2000-11-17 | ||
US60/249,215 | 2000-11-17 | ||
US60/250,160 | 2000-12-01 | ||
US60/250,391 | 2000-12-01 | ||
US60/256,719 | 2000-12-05 | ||
US60/251,988 | 2000-12-05 | ||
US60/251,030 | 2000-12-05 | ||
US60/251,479 | 2000-12-06 | ||
US60/251,856 | 2000-12-08 | ||
US60/251,989 | 2000-12-08 | ||
US60/251,868 | 2000-12-08 | ||
US60/251,869 | 2000-12-08 | ||
US60/251,990 | 2000-12-08 | ||
US60/254,097 | 2000-12-11 | ||
US60/259,678 | 2001-01-05 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001055327A2 WO2001055327A2 (fr) | 2001-08-02 |
WO2001055327A8 true WO2001055327A8 (fr) | 2001-09-07 |
WO2001055327A3 WO2001055327A3 (fr) | 2002-02-28 |
Family
ID=27587117
Family Applications (48)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/001340 WO2001055321A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001324 WO2001055314A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001306 WO2001055307A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001344 WO2001055324A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001341 WO2001055322A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001354 WO2001057182A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001335 WO2001055319A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001350 WO2001055350A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001338 WO2001055367A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et antigenes |
PCT/US2001/001312 WO2001054733A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001328 WO2001055316A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001342 WO2001059064A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001351 WO2001055355A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001325 WO2001055202A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001321 WO2001055312A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001239 WO2001055301A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001301 WO2001055303A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001353 WO2001055206A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001358 WO2001055163A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines, et anticorps |
PCT/US2001/001337 WO2001055205A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001345 WO2001055325A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001309 WO2001055308A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001349 WO2001054474A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001352 WO2001055327A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001315 WO2001055311A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001313 WO2001055200A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001317 WO2001055201A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001333 WO2001055448A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001308 WO2001055364A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucléiques, protéines et anticorps |
PCT/US2001/001316 WO2001054473A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001348 WO2001055368A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001322 WO2001055343A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001240 WO2001055302A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001310 WO2001055387A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001339 WO2001055320A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001330 WO2001055447A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucléiques, proteines et anticorps |
PCT/US2001/001343 WO2001055323A2 (fr) | 2000-01-31 | 2001-01-17 | Acides ncleiques, proteines et anticorps |
PCT/US2001/001336 WO2001055204A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001359 WO2001055328A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001356 WO2001055173A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001314 WO2001055310A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001327 WO2001055203A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001332 WO2001055318A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001357 WO2001055208A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001302 WO2001055304A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001326 WO2001055315A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines, et anticorps |
PCT/US2001/001355 WO2001055207A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001311 WO2001055309A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
Family Applications Before (23)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/001340 WO2001055321A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001324 WO2001055314A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001306 WO2001055307A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001344 WO2001055324A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001341 WO2001055322A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001354 WO2001057182A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001335 WO2001055319A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001350 WO2001055350A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001338 WO2001055367A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et antigenes |
PCT/US2001/001312 WO2001054733A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001328 WO2001055316A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001342 WO2001059064A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001351 WO2001055355A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001325 WO2001055202A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001321 WO2001055312A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001239 WO2001055301A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001301 WO2001055303A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001353 WO2001055206A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001358 WO2001055163A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines, et anticorps |
PCT/US2001/001337 WO2001055205A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001345 WO2001055325A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001309 WO2001055308A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001349 WO2001054474A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
Family Applications After (24)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/001315 WO2001055311A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001313 WO2001055200A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001317 WO2001055201A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001333 WO2001055448A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001308 WO2001055364A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucléiques, protéines et anticorps |
PCT/US2001/001316 WO2001054473A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001348 WO2001055368A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001322 WO2001055343A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001240 WO2001055302A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001310 WO2001055387A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001339 WO2001055320A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001330 WO2001055447A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucléiques, proteines et anticorps |
PCT/US2001/001343 WO2001055323A2 (fr) | 2000-01-31 | 2001-01-17 | Acides ncleiques, proteines et anticorps |
PCT/US2001/001336 WO2001055204A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001359 WO2001055328A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001356 WO2001055173A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001314 WO2001055310A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001327 WO2001055203A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001332 WO2001055318A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001357 WO2001055208A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001302 WO2001055304A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001326 WO2001055315A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines, et anticorps |
PCT/US2001/001355 WO2001055207A1 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
PCT/US2001/001311 WO2001055309A2 (fr) | 2000-01-31 | 2001-01-17 | Acides nucleiques, proteines et anticorps |
Country Status (3)
Country | Link |
---|---|
AU (16) | AU2001241408A1 (fr) |
CA (37) | CA2395295A1 (fr) |
WO (48) | WO2001055321A2 (fr) |
Families Citing this family (271)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001070982A2 (fr) * | 2000-03-23 | 2001-09-27 | Immusol Incorporated | Regulateurs de brca-1 et procedes d'utilisation |
US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US6960570B2 (en) | 1998-03-18 | 2005-11-01 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6706262B1 (en) | 1998-03-18 | 2004-03-16 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US7258860B2 (en) | 1998-03-18 | 2007-08-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US7579160B2 (en) | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
DE69936382T3 (de) | 1998-05-15 | 2011-07-07 | Genentech, Inc., Calif. | Therapeutische verwendungen von il-17 homologe polypeptide |
US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
US6929938B2 (en) | 2001-08-15 | 2005-08-16 | Millennium Pharmaceuticals, Inc. | 25501, a human transferase family member and uses therefor |
US7141417B1 (en) | 1999-02-25 | 2006-11-28 | Thomas Jefferson University | Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene |
EP1163252A4 (fr) * | 1999-02-25 | 2004-04-07 | Univ Jefferson | Compositions, kits et procedes concernant le gene fez1 de l'homme, nouveau gene suppresseur des tumeurs |
EP1157038A4 (fr) * | 1999-02-26 | 2005-01-19 | Smithkline Beecham Corp | Clonage du recepteur 7tm (axor 17) du type p2y |
EP1169440A4 (fr) * | 1999-03-23 | 2004-01-14 | Human Genome Sciences Inc | 48 proteines humaines secretees |
WO2000058480A1 (fr) | 1999-03-29 | 2000-10-05 | Kansai Technology Licensing Organization Co., Ltd. | Nouvelle cytidine desaminase |
EP1621620A3 (fr) * | 1999-09-01 | 2006-05-10 | Genetech, Inc. | Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci |
US7083944B1 (en) * | 1999-10-27 | 2006-08-01 | Millennium Pharmaceuticals, Inc. | Molecules of the card-related protein family and uses thereof |
US6893818B1 (en) | 1999-10-28 | 2005-05-17 | Agensys, Inc. | Gene upregulated in cancers of the prostate |
US7005499B1 (en) * | 1999-11-18 | 2006-02-28 | Genentech, Inc. | Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same |
EP1878795A3 (fr) * | 1999-11-30 | 2008-01-23 | Genentech, Inc. | Compositions et procédés pour le traitement de maladies liées au système immunitaire |
CA2492070A1 (fr) * | 1999-12-01 | 2001-06-07 | Kevin P. Baker | Polypeptides pro4329 marqueurs de tumeurs du poumon et acides nucleiques codant lesdits polypeptides |
CN1300781A (zh) * | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | 一种新的多肽-人shc蛋白43和编码这种多肽的多核苷酸 |
US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
US7510855B2 (en) | 2000-01-26 | 2009-03-31 | Agensys, Inc. | 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer |
US6953682B2 (en) | 2000-02-10 | 2005-10-11 | Millennium Pharmaceuticals, Inc. | Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor |
US7078205B2 (en) | 2000-02-17 | 2006-07-18 | Millennium Pharmaceuticals, Inc. | Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor |
US20020082212A1 (en) * | 2000-07-20 | 2002-06-27 | Millennium Pharmaceuticals, Inc. | 7716, a novel human ATPase and uses therefor |
US20020031815A1 (en) * | 2000-06-26 | 2002-03-14 | Millennium Pharmaceuticals, Inc. | 46619, a novel human beta-ketoacyl synthase and uses thereof |
US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
US20020025931A1 (en) | 2000-03-24 | 2002-02-28 | Rachel Meyers | 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor |
US20030198953A1 (en) * | 2000-03-30 | 2003-10-23 | Spytek Kimberly A. | Novel proteins and nucleic acids encoding same |
US7632929B2 (en) | 2000-04-20 | 2009-12-15 | The Board Of Trustees Of The University Of Arkansas | Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof |
CA2407044A1 (fr) | 2000-04-25 | 2001-11-01 | Lexicon Genetics Incorporated | Nouvelles proteines kinases humaines et polynucleotides les codant |
WO2001081586A2 (fr) * | 2000-04-26 | 2001-11-01 | Millennium Pharmaceuticals, Inc. | 21657, deshydrogenase humaine a chaine courte et ses utilisations |
US6808876B1 (en) * | 2000-05-02 | 2004-10-26 | Immusol, Inc. | Cellular regulators of infectious agents and methods of use |
CA2408828A1 (fr) * | 2000-05-12 | 2001-11-15 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Nouvelle serine-threonine kinase-4 |
EP1158001B1 (fr) * | 2000-05-26 | 2007-11-14 | F. Hoffmann-La Roche Ag | Un acide nucléique produit excessivement dans des cellules tumorales humaines, une protéine codée par ledit acide nucléique et un procédé de diagnose de tumeurs |
AU7634301A (en) * | 2000-05-26 | 2001-12-03 | Bayer Aktiengesellschaft | Regulation of human p78-like serine/threonine kinase |
DE10027170A1 (de) * | 2000-05-31 | 2001-12-13 | Schering Ag | Humanes PEM als Target für die Fertilitätskontrolle |
US7098311B2 (en) * | 2000-06-02 | 2006-08-29 | Brigham And Women's Hospital | Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors |
AU6531101A (en) * | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO2001094385A2 (fr) * | 2000-06-05 | 2001-12-13 | Bayer Aktiengesellschaft | Regulation du recepteur couple a la proteine humaine g de type hm74 |
JP2004512023A (ja) * | 2000-06-09 | 2004-04-22 | コリクサ コーポレイション | 結腸癌の治療および診断のための組成物および方法 |
US6323016B1 (en) | 2000-06-09 | 2001-11-27 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
AU2001268435A1 (en) * | 2000-06-15 | 2001-12-24 | Millennium Pharmaceuticals, Inc. | 23680, a novel human aminotransferase and uses therefor |
WO2001096546A2 (fr) * | 2000-06-16 | 2001-12-20 | Incyte Genomics, Inc. | Proteine-phosphatases |
CA2648048A1 (fr) * | 2000-06-23 | 2002-01-03 | Genentech, Inc. | Compositions et procedes de diagnostic et de traitement de troubles dont l'angiogenese |
US7094587B2 (en) | 2000-06-27 | 2006-08-22 | Millennium Pharmaceuticals, Inc. | 16002 Molecules and uses therefor |
EP1309684A2 (fr) * | 2000-06-27 | 2003-05-14 | Curagen Corporation | Polynucleotides et polypeptides codes par ceux-ci |
WO2002000939A2 (fr) | 2000-06-28 | 2002-01-03 | Diadexus, Inc. | Procede de diagnostic, de surveillance, de determination du stade, d'imagerie et de traitement du cancer du colon |
AU2001273148A1 (en) * | 2000-06-30 | 2002-01-14 | Millennium Pharmaceuticals, Inc. | 57658, a human uridine kinase and uses thereof |
WO2002004510A2 (fr) * | 2000-07-07 | 2002-01-17 | Incyte Genomics, Inc. | Proteines liant le nucleotide guanine |
JP2004513618A (ja) * | 2000-07-07 | 2004-05-13 | インサイト・ゲノミックス・インコーポレイテッド | 輸送体及びイオンチャネル |
WO2002006326A2 (fr) * | 2000-07-14 | 2002-01-24 | Millennium Pharmaceuticals, Inc. | 62088, un nouveau membre humain de la famille nucleoside phosphatase, et utilisations de ce dernier |
AU2001281967A1 (en) * | 2000-07-18 | 2002-01-30 | Bayer Aktiengesellschaft | Regulation of human desc1-like serine protease |
WO2002006318A2 (fr) | 2000-07-18 | 2002-01-24 | Board Of Regents, The University Of Texas System | Procedes et compositions permettant de stabiliser des microtubules et des filaments intermediaires dans des cellules de muscle strie |
CA2416456A1 (fr) * | 2000-07-20 | 2002-01-31 | Genentech, Inc. | Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides |
AU8762901A (en) * | 2000-07-25 | 2002-02-05 | Merck Patent Gmbh | Novel protein containing ring finger domaine r1p4 |
AU2001277202A1 (en) * | 2000-07-26 | 2002-02-05 | Applied Genomics, Inc. | Bstp-ras/rerg protein and related reagents and methods of use thereof |
WO2002008281A2 (fr) * | 2000-07-26 | 2002-01-31 | Stanford University | Proteine bstp-cad et reactifs associes et methodes d'utilisation |
EP1657254A3 (fr) * | 2000-08-01 | 2006-06-07 | Genentech, Inc. | Polypeptide, acides nucléiques le codant, et leur utilisation pour le diagnostic du cancer |
US7335732B2 (en) | 2000-08-01 | 2008-02-26 | Genentech, Inc. | PRO9799 polypeptides |
WO2002010217A2 (fr) | 2000-08-02 | 2002-02-07 | The Johns Hopkins University | Profils d'expression de cellules endotheliales |
EP1315431A1 (fr) * | 2000-08-02 | 2003-06-04 | Millennium Pharmaceuticals, Inc. | Membre de la famille du facteur de liberation du gtp humain (15368) et ses utilisations |
US6924364B2 (en) | 2000-08-04 | 2005-08-02 | Zymogenetics, Inc. | Human secreted protein, Zzp1 |
AU2001281252A1 (en) | 2000-08-10 | 2002-02-18 | Board Of Regents, The University Of Texas System | The tumor suppressor car-1 |
AU9174501A (en) * | 2000-08-11 | 2002-02-25 | Merck Patent Gmbh | Novel mitogen activated kinase |
EP1326985A1 (fr) * | 2000-08-18 | 2003-07-16 | MERCK PATENT GmbH | Identification d'un gene d'acetyltransferase n-terminale humaine |
AU2001285109A1 (en) * | 2000-08-21 | 2002-03-04 | Incyte Genomics, Inc. | Microtubule-associated proteins and tubulins |
US6706513B2 (en) | 2000-08-21 | 2004-03-16 | Bristol-Myers Squibb Company | Adenosine deaminase homolog |
WO2002016579A2 (fr) * | 2000-08-24 | 2002-02-28 | Eli Lilly And Company | Acides nucleiques, vecteurs, cellules hotes, polypeptides et utilisations de ces derniers |
CA2420902A1 (fr) * | 2000-08-28 | 2002-03-07 | Craig A. Rosen | 18 proteines humaines secretees |
AU2001284176A1 (en) * | 2000-08-28 | 2002-03-13 | Astrazeneca Ab | Molecules involved in the regulation of insulin in resistance syndrome (irs) |
EP2022797A3 (fr) | 2000-08-28 | 2011-11-09 | Agensys, Inc. | Acide nucléique et protéine correspondante intitulée 85P1B3 utile dans le traitement et la détection du cancer |
US20030224396A1 (en) * | 2000-08-30 | 2003-12-04 | Yonghong Xiao | Regulation of human aminotransferase-like enzyme |
US20020091238A1 (en) * | 2000-08-30 | 2002-07-11 | Curtis Rory A.J. | 54370, a novel human sulfate transporter and uses therefor |
US20020146800A1 (en) * | 2000-08-30 | 2002-10-10 | Curtis Rory A.J. | 48921, a novel human GTP releasing factor and uses therefor |
AU2002210464A1 (en) * | 2000-08-30 | 2002-03-13 | Bayer Aktiengesellschaft | Regulation of human aminotransferase-like enzyme |
AU2001288600A1 (en) * | 2000-08-31 | 2002-03-13 | Millennium Pharmaceuticals, Inc. | 62112, a novel human dehydrogenase and uses thereof |
WO2002020762A2 (fr) | 2000-09-05 | 2002-03-14 | Amgen Inc. | Molecules analogues au recepteur du tnf et ses utilisations |
CA2421265A1 (fr) * | 2000-09-05 | 2002-03-14 | Incyte Genomics, Inc. | Molecules utilisees a des fins diagnostiques et therapeutiques |
AU2001288999A1 (en) * | 2000-09-08 | 2002-03-22 | Millennium Pharmaceuticals, Inc. | 38646, a guanine nucleotide exchange factor and uses therefor |
US6391606B1 (en) * | 2000-09-14 | 2002-05-21 | Pe Corporation | Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
US6372468B1 (en) * | 2000-09-14 | 2002-04-16 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
EP1349930A2 (fr) * | 2000-10-05 | 2003-10-08 | Curagen Corporation | Polypeptides humains, acides nucleiques codant ces deuniers et leurs methodes d'utilisation |
EP1402010A2 (fr) * | 2000-10-11 | 2004-03-31 | Millennium Pharmaceuticals, Inc. | Nouvel element de la famille des phosphatases humaines a double specificite, appele 8843, et utilisation de ce dernier |
AU2002220613A1 (en) * | 2000-10-11 | 2002-04-22 | Bayer Aktiengesellschaft | Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase |
WO2002031143A2 (fr) * | 2000-10-12 | 2002-04-18 | The Texas A & M University System | Sequences d'acides nucleiques codant des proteines cmg, proteines cmg et leurs procedes d'utilisation |
EP1474528A4 (fr) * | 2000-10-13 | 2006-06-14 | Protein Design Labs Inc | Procedes de diagnostic du cancer de la prostate, compositions et procedes de criblage de modulateurs du cancer de la prostate |
US6531297B2 (en) * | 2000-10-20 | 2003-03-11 | Applera Corporation | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
JP2004518437A (ja) | 2000-10-25 | 2004-06-24 | ディアデクサス インコーポレーテッド | 肺特異的遺伝子およびタンパク質に関する組成物および方法 |
AU2002220668A1 (en) * | 2000-10-31 | 2002-05-15 | Bayer Aktiengesellschaft | Regulation of human glutathione-s-transferase |
AU2002229011A1 (en) * | 2000-11-09 | 2002-05-21 | Glaxo Group Limited | Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp |
WO2002040672A2 (fr) | 2000-11-20 | 2002-05-23 | Diadexus, Inc. | Compositions et methodes relatives a des genes et des proteines specifiques aux seins |
WO2002081667A2 (fr) * | 2000-12-05 | 2002-10-17 | Incyte Genomics, Inc. | Ligases |
CA2430379A1 (fr) | 2000-12-07 | 2002-06-13 | Chiron Corporation | Retrovirus endogenes regules positivement dans le cancer de la prostate |
AU2002226033A1 (en) | 2000-12-07 | 2002-06-18 | Zymogenetics Inc. | Adipocyte complement related protein zacrp3x2 |
CA2439800A1 (fr) * | 2000-12-14 | 2002-06-20 | Pe Corporation (Ny) | Proteines kinases humaines isolees, molecules d'acide nucleique codant des proteines kinases humaines et utilisations associees |
US20020142376A1 (en) * | 2000-12-20 | 2002-10-03 | Gennady Merkulov | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
US6858407B2 (en) | 2000-12-22 | 2005-02-22 | Bristol-Myers Squibb Company | Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
US7892730B2 (en) | 2000-12-22 | 2011-02-22 | Sagres Discovery, Inc. | Compositions and methods for cancer |
US6423521B1 (en) * | 2000-12-28 | 2002-07-23 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
WO2002053591A1 (fr) * | 2000-12-30 | 2002-07-11 | Lion Bioscience Ag | Cofacteur de recepteur nucleaire mammalien cf12 et ses procedes d'utilisation |
AU2002236717A1 (en) * | 2001-01-08 | 2002-07-16 | Lexicon Genetics Incorporated | Human protease and polynucleotides encoding the same |
AU2002243750A1 (en) * | 2001-01-30 | 2002-08-12 | Regeneron Pharmaceuticals, Inc. | Novel nucleic acid and polypeptide molecules |
WO2002098917A2 (fr) * | 2001-02-12 | 2002-12-12 | Curagen Corporation | Proteines, polynucleotides codant pour lesdites proteines et methodes d'utilisation desdites proteines |
EP1637601A3 (fr) * | 2001-02-21 | 2006-03-29 | Curagen Corporation | Protéines , polynucléotides codant pour ces protéines et procédés d'utilisation |
US7271240B2 (en) | 2001-03-14 | 2007-09-18 | Agensys, Inc. | 125P5C8: a tissue specific protein highly expressed in various cancers |
EP1434783A4 (fr) * | 2001-03-16 | 2006-06-07 | Lilly Co Eli | Proteines de mammiferes lp et reactifs associes |
US6913904B2 (en) * | 2001-03-27 | 2005-07-05 | Applera Corporation | Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
AU2002258626B2 (en) | 2001-04-10 | 2007-01-18 | Agensys, Inc. | Nucleid acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
CA2443123A1 (fr) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers |
ATE512216T1 (de) | 2001-04-10 | 2011-06-15 | Agensys Inc | Nukleinsäure und dieser entsprechendes, 184p1e2 genanntes, für die behandlung und den nachweis von krebs geeignetes protein |
JP2004532030A (ja) * | 2001-04-24 | 2004-10-21 | イシス・イノベイション・リミテッド | 疾病用酵素とsnpマーカー |
WO2002088175A1 (fr) * | 2001-04-24 | 2002-11-07 | Otsuka Pharmaceutical Co., Ltd. | Peptide de liaison a des anticorps de la maladie de crohn et methode d'examen de ladite maladie |
KR100882762B1 (ko) * | 2001-05-07 | 2009-02-09 | 시오노기세이야쿠가부시키가이샤 | 혈관신생 마커로서 사용되는 폴리펩티드 및 이의 dna |
WO2002090543A2 (fr) * | 2001-05-09 | 2002-11-14 | Bayer Aktiengesellschaft | Régulation de la protéine semblable à celle de type 2c de la phosphatase de l'acide phosphatidique humain |
US7157558B2 (en) | 2001-06-01 | 2007-01-02 | Genentech, Inc. | Polypeptide encoded by a polynucleotide overexpresses in tumors |
US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
US7235358B2 (en) * | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
WO2003000901A2 (fr) * | 2001-06-26 | 2003-01-03 | Decode Genetics Ehf. | Acides nucleiques codant des proteines kinases |
GB2399087A (en) * | 2001-08-02 | 2004-09-08 | Aeomica Inc | Human zinc finger containing gene MDZ7 |
JP2005504546A (ja) * | 2001-08-17 | 2005-02-17 | インサイト・ゲノミックス・インコーポレイテッド | 細胞内シグナル伝達分子 |
US7270960B2 (en) * | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
WO2003023063A1 (fr) * | 2001-09-07 | 2003-03-20 | Sankyo Company, Limited | Methode d'estimation du risque d'apparition de diabetes |
WO2003040369A2 (fr) * | 2001-09-17 | 2003-05-15 | Molecular Engines Laboratories | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments |
WO2003025175A2 (fr) * | 2001-09-17 | 2003-03-27 | Molecular Engines Laboratories | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments |
EP1463806B1 (fr) | 2001-09-28 | 2011-01-05 | Brigham Young University | Nouveaux variants de la cyclooxygenase et methodes d'utilisation |
WO2003038087A1 (fr) | 2001-10-04 | 2003-05-08 | Kansai Technology Licensing Organization Co., Ltd. | Promoteur du gene dr5 et promoteur du gene siah-1 |
US7084257B2 (en) | 2001-10-05 | 2006-08-01 | Amgen Inc. | Fully human antibody Fab fragments with human interferon-gamma neutralizing activity |
WO2003031607A1 (fr) * | 2001-10-10 | 2003-04-17 | Bayer Healthcare Ag | Regulation de deshydrogenase/reductase des chaines courtes humaine |
ATE364690T1 (de) | 2001-11-09 | 2007-07-15 | Proteologics Inc | Posh nukleinsäure, polypeptide und darauf bezogene verfahren |
US7491690B2 (en) | 2001-11-14 | 2009-02-17 | Northwestern University | Self-assembly and mineralization of peptide-amphiphile nanofibers |
JPWO2003044197A1 (ja) * | 2001-11-21 | 2005-03-24 | 独立行政法人科学技術振興機構 | ハンチントン病遺伝子転写因子 |
US7151162B2 (en) | 2001-12-06 | 2006-12-19 | The University Of Children's Hospital Of Both Cantons Of Basel | Nuclear protein |
AU2002339697A1 (en) * | 2001-12-19 | 2003-06-30 | Genset S.A. | Gmg-5 polynucleotides and polypeptides and uses thereof |
JP2003245084A (ja) | 2001-12-20 | 2003-09-02 | Morinaga Milk Ind Co Ltd | 脳梁又は精子の形成不全の診断及び治療に有用な新規遺伝子、並びにその用途 |
DE10163467A1 (de) * | 2001-12-21 | 2003-11-27 | Axaron Bioscience Ag | Protein 24B2 und zugrundliegende DNA-Sequenz |
US6759222B2 (en) | 2002-01-02 | 2004-07-06 | Millennium Pharmaceuticals, Inc. | 14815, a human kinase family member and uses therefor |
AU2003202543A1 (en) * | 2002-01-07 | 2003-07-24 | Bayer Aktiengesellschaft | Human phosphatidic acid phosphatase type 2-like protein |
WO2003060109A2 (fr) * | 2002-01-15 | 2003-07-24 | Bayer Healthcare Ag | Regulation d'une subtilase humaine |
WO2003059948A1 (fr) * | 2002-01-15 | 2003-07-24 | Medigene Ag | Gene-2 associe a la myocardiopathie dilatee (dcmag-2) : inducteur cytoplasmique du remodelage sarcomerique de cardiomyocytes |
JPWO2003062429A1 (ja) * | 2002-01-23 | 2005-05-26 | 山之内製薬株式会社 | 新規セリンプロテアーゼ |
US7371719B2 (en) | 2002-02-15 | 2008-05-13 | Northwestern University | Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
EP1338609A1 (fr) * | 2002-02-21 | 2003-08-27 | MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln | Un outre récepteur KDR et son utilisation |
EP1497311A2 (fr) * | 2002-03-05 | 2005-01-19 | Applera Corporation | Proteines transporteuses humaines isolees, molecules d'acide nucleique codant celles-ci, et utilisations associees |
AU2003208472A1 (en) * | 2002-03-06 | 2003-09-16 | Oxford Glycosciences (Uk) Ltd | Novel b-cell malignancy-associated protein |
DK2258872T3 (da) | 2002-03-13 | 2013-11-18 | Genomic Health Inc | Genekspressionsprofilering i biopsier af tumorvæv |
JP3949111B2 (ja) * | 2002-03-19 | 2007-07-25 | 田辺製薬株式会社 | 新規gタンパク質共役型受容体およびその遺伝子 |
US7527935B2 (en) | 2002-03-19 | 2009-05-05 | Mitsubishi Tanabe Pharma Corporation | G-protein coupled receptor having eicosanoid as ligand and gene thereof |
GB0206684D0 (en) * | 2002-03-21 | 2002-05-01 | Babraham Inst | Novel proteins |
US7193069B2 (en) * | 2002-03-22 | 2007-03-20 | Research Association For Biotechnology | Full-length cDNA |
US7329502B2 (en) | 2002-04-25 | 2008-02-12 | The United States Of America As Represented By The Department Of Health And Human Services | ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) |
JP2004041003A (ja) * | 2002-05-17 | 2004-02-12 | Takeda Chem Ind Ltd | 新規タンパク質、そのdnaおよびその用途 |
AU2003238178A1 (en) | 2002-05-29 | 2003-12-12 | Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung | Pancreas-specific proteins |
WO2003101401A2 (fr) | 2002-06-03 | 2003-12-11 | Chiron Corporation | Utilisation de nrg4, ou d'inhibiteurs de nrg4, dans le traitement du cancer du colon et du pancreas |
EP1513934B1 (fr) | 2002-06-06 | 2011-03-02 | Oncotherapy Science, Inc. | Genes et polypeptides en rapport avec les cancers du colon chez l'homme |
AU2003276679A1 (en) | 2002-06-13 | 2003-12-31 | Chiron Corporation | Vectors for expression of hml-2 polypeptides |
CA2493263A1 (fr) * | 2002-07-22 | 2004-01-29 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveau gene associe a l'arthrite rhumatoide |
JP4186004B2 (ja) | 2002-08-14 | 2008-11-26 | 独立行政法人産業技術総合研究所 | 新規n−アセチルガラクトサミン転移酵素およびそれをコードする核酸 |
WO2004016733A2 (fr) | 2002-08-16 | 2004-02-26 | Agensys, Inc. | Acides nucleiques et proteines correspondantes connues sous 251p5g2 que l'on utilise dans le traitement et la detection de cancers |
WO2004018518A1 (fr) * | 2002-08-23 | 2004-03-04 | Japan Science And Technology Agency | Peptides antigeniques de tumeur cancereuse solide humains, polynucleotides codant pour ceux-ci et utilisation de ceux-ci |
EP1540014A2 (fr) * | 2002-08-27 | 2005-06-15 | Epigenomics AG | Procede et acides nucleiques servant a l'analyse de troubles lies a la proliferation des cellules mammaires |
US7452969B2 (en) | 2002-08-30 | 2008-11-18 | Licentia Ltd | Neurotrophic factor protein and uses thereof |
CA2500472A1 (fr) | 2002-09-30 | 2004-04-15 | Oncotherapy Science, Inc. | Genes et polypeptides associes aux cancers du pancreas chez l'homme |
WO2004035823A2 (fr) * | 2002-10-17 | 2004-04-29 | Evotec Neurosciences Gmbh | Utilisation diagnostique et therapeutique des gene et proteine ensadin-0625 destinee a des maladies neurodegeneratives |
AU2002952216A0 (en) * | 2002-10-23 | 2002-11-07 | The Walter And Eliza Hall Institute Of Medical Research | Novel therapeutic molecules |
US7554021B2 (en) | 2002-11-12 | 2009-06-30 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
EP1570080A4 (fr) | 2002-11-15 | 2006-03-01 | Genomic Health Inc | Etablissement de profils d'expressions genetique du cancer a recepteur de facteur de croissance epidermique positif |
DE10254601A1 (de) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
AU2002953341A0 (en) * | 2002-12-13 | 2003-01-09 | The Walter And Eliza Hall Institute Of Medical Research | A novel phosphoprotein |
AU2003287764B2 (en) * | 2002-12-13 | 2010-01-21 | The Walter And Eliza Hall Institute Of Medical Research | A novel phosphoprotein |
US20040231909A1 (en) | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
WO2004070025A2 (fr) * | 2003-02-05 | 2004-08-19 | Juan Saus | Nouvelles isoformes de la proteine liant l'antigene de goodpasture et troubles induits par une proteine incorrectement repliee |
EP1445614A1 (fr) * | 2003-02-06 | 2004-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Méthodes d'évaluation in vitro de l'état de progression d'un virus HIV chez un individu |
US7074891B2 (en) | 2003-02-07 | 2006-07-11 | Posco | Leukocyte stimulating peptides |
EP1597391B1 (fr) | 2003-02-20 | 2008-10-29 | Genomic Health, Inc. | Utilisation d'arn intronique pour mesurer l'expression genique |
US20060142222A1 (en) * | 2003-03-04 | 2006-06-29 | Makoto Ogino | Novel gene relating to fibrotic conditions |
EP1606409B1 (fr) * | 2003-03-19 | 2010-09-01 | Biogen Idec MA Inc. | Proteine de liaison de recepteur de nogo |
ITRM20030149A1 (it) | 2003-04-02 | 2004-10-03 | Giuliani Spa | Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico |
EP3170906B1 (fr) | 2003-06-24 | 2018-08-22 | Genomic Health, Inc. | Prédiction de probabilité de récurrence de cancer |
WO2005008213A2 (fr) | 2003-07-10 | 2005-01-27 | Genomic Health, Inc. | Algorithme de profile d'expression et test du pronostic du cancer |
EP1652923B1 (fr) | 2003-08-08 | 2011-10-12 | Perseus Proteomics Inc. | Gene surexprime dans le cancer |
WO2005018554A2 (fr) * | 2003-08-12 | 2005-03-03 | Washington University In St. Louis | Proteine de surface cellulaire isolee inductible par la chaleur et therapie d'immunociblage de tumeurs basee sur l'hyperthermie |
US20070178458A1 (en) * | 2003-09-05 | 2007-08-02 | O'brien Philippa | Methods of diagnosis and prognosis of ovarian cancer II |
TW200517503A (en) * | 2003-09-10 | 2005-06-01 | Japan Science & Tech Agency | Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same |
WO2005032584A2 (fr) * | 2003-10-02 | 2005-04-14 | Glaxosmithkline Biologicals S.A. | Composes |
MXPA06003686A (es) | 2003-10-03 | 2007-03-01 | Brigham & Womens Hospital | Ligandos tim-3 y sus metodos. |
WO2005040791A2 (fr) * | 2003-10-21 | 2005-05-06 | Bayer Healthcare Ag | Diagnostics et therapeutiques pour maladies liees au recepteur de peptides similaire a la somatostatine et a l'angiogenine (salpr) |
WO2005051994A2 (fr) * | 2003-11-21 | 2005-06-09 | Zymogenetics, Inc. | Facteur de necrose tumorale ztnf11 |
ATE541580T1 (de) | 2003-12-05 | 2012-02-15 | Univ Northwestern | Selbst anordnende peptid-amphiphile und relevante verfahren für die abgabe von wachstumsfaktor |
WO2005064019A2 (fr) | 2003-12-23 | 2005-07-14 | Genomic Health, Inc. | Amplification universelle d'arn fragmente |
US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
ES2537633T3 (es) | 2004-03-02 | 2015-06-10 | The Johns Hopkins University | Mutaciones del gen de PIK3CA en cánceres humanos |
TW200539890A (en) | 2004-03-12 | 2005-12-16 | Brigham & Womens Hospital | Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
WO2005090569A1 (fr) * | 2004-03-24 | 2005-09-29 | The Council Of The Queensland Institute Of Medical Research | Cancer et acides nucleiques et proteines de testicule vsm1 et vsm2, et leurs utilisations |
EP2289911A3 (fr) * | 2004-03-30 | 2011-03-30 | NsGene A/S | Utilisation thérapeutique du facteur de croissance nsg33 |
CA2563074C (fr) | 2004-04-09 | 2014-05-20 | Genomic Health, Inc. | Marqueurs d'expression genique permettant de predire la reponse a la chimiotherapie |
DE102004024617A1 (de) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
WO2005118832A2 (fr) * | 2004-06-01 | 2005-12-15 | Bayer Healthcare Ag | Agents diagnostiques et therapeutiques pour des maladies associees a une proteine de type kinase regulee par serum/glucocorticoide (sgkl) |
JP4960865B2 (ja) | 2004-06-24 | 2012-06-27 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 脱髄に関連する状態の処置 |
US7587279B2 (en) | 2004-07-06 | 2009-09-08 | Genomic Health | Method for quantitative PCR data analysis system (QDAS) |
US7985831B2 (en) * | 2004-08-05 | 2011-07-26 | Toagosei Co., Ltd. | Crohn's disease antibody epitope peptide and reagent for testing Crohn's disease |
PL1836629T3 (pl) | 2004-11-05 | 2020-06-15 | Genomic Health, Inc. | Przewidywanie odpowiedzi na chemioterapię z zastosowaniem markerów ekspresji genu |
ATE550440T1 (de) | 2004-11-05 | 2012-04-15 | Genomic Health Inc | Molekulare indikatoren für brustkrebsprognose und vorhersage des ansprechens auf eine behandlung |
US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
KR101027427B1 (ko) | 2004-11-12 | 2011-04-11 | 젠코어 인코포레이티드 | FcRn에 대하여 증가된 결합력을 갖는 Fc 변이체 |
CA2598251A1 (fr) | 2005-03-04 | 2006-09-14 | Northwestern University | Epitopes angiogeniques de liaison a l'heparine, amphiphiles peptidiques, compositions auto-assemblees et procedes d'utilisation associes |
CA2608315C (fr) * | 2005-05-13 | 2014-08-05 | Centre National De La Recherche Scientifique | Utilisation de nouveau codage genique pour nouvel element de la famille mcm2-8 dans les compositions pharmaceutiques |
KR101245462B1 (ko) | 2005-07-08 | 2013-03-20 | 바이오겐 아이덱 엠에이 인코포레이티드 | Sp35 항체 및 그의 용도 |
EP1907589A4 (fr) * | 2005-07-26 | 2010-11-24 | Siemens Healthcare Diagnostics | Polymorphismes de nucleotides uniques a susceptibilite par rapport a une maladie cardio-vasculaire |
US8207128B2 (en) * | 2005-09-28 | 2012-06-26 | Supadelixir Inc. | Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof |
EP1790664A1 (fr) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Anticorps monoclonaux contre claudin-18 pour le traitement du cancer |
JP5236488B2 (ja) | 2005-12-14 | 2013-07-17 | ハーモ ファーマ エルテーデー. | 新規な神経栄養因子タンパク質およびその用途 |
WO2008003656A2 (fr) * | 2006-07-03 | 2008-01-10 | Exonhit Therapeutics Sa | Produits de la transcription spécifiques de la prostate et leur utilisation pour des thérapeutiques et des diagnostics du cancer de la prostate |
US20080108070A1 (en) * | 2006-09-08 | 2008-05-08 | Corixa Corporation | Methods, compositions, and kits for the detection and monitoring of colon cancer |
US8076295B2 (en) | 2007-04-17 | 2011-12-13 | Nanotope, Inc. | Peptide amphiphiles having improved solubility and methods of using same |
US8999634B2 (en) * | 2007-04-27 | 2015-04-07 | Quest Diagnostics Investments Incorporated | Nucleic acid detection combining amplification with fragmentation |
GB0805159D0 (en) | 2008-03-19 | 2008-04-23 | Sancho Madrid David | Immune modulation via C-type lectin |
EP2565204B1 (fr) | 2007-07-27 | 2015-10-07 | immatics biotechnologies GmbH | Nouveaux épitopes immunogènes pour l'immunothérapie |
US7863021B2 (en) * | 2007-09-05 | 2011-01-04 | Celera Corporation | Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof |
WO2009034661A1 (fr) * | 2007-09-12 | 2009-03-19 | Toppan Printing Co., Ltd. | Procédé de diagnostic et induction d'une résistance à un virus |
EP2216340B1 (fr) | 2007-10-17 | 2012-12-12 | Universidad De Córdoba | Isoformes du récepteur de la somatostatine humaine de type 5 produites par traitement alternatif et paires d'oligonucléotides permettant de les détecter par pcr |
SI2235059T1 (sl) | 2007-12-26 | 2015-06-30 | Xencor, Inc. | Fc variante s spremenjeno vezjo na fcrn |
GB0803352D0 (en) * | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
EP3112379A1 (fr) * | 2008-03-21 | 2017-01-04 | Universiteit Hasselt | Biomarqueurs pour la polyarthrite rhumatoïde |
EP2315779A2 (fr) | 2008-07-09 | 2011-05-04 | Biogen Idec MA Inc. | Compositions comprenant des anticorps anti-lingo ou leurs fragments |
CN102164611B (zh) | 2008-07-24 | 2015-01-07 | Ns基因公司 | 生长因子metrnl的治疗用途 |
SI2172211T1 (sl) | 2008-10-01 | 2015-03-31 | Immatics Biotechnologies Gmbh | Sestavek s tumorjem povezanih peptidov in zadevnih cepiv proti raku za zdravljenje glioblastoma (GBM) in drugih vrst raka |
AU2009313808B2 (en) | 2008-11-14 | 2013-05-16 | Gen-Probe Incorporated | Compositions, kits and methods for detection of campylobacter nucleic acid |
US20110229471A1 (en) | 2008-11-26 | 2011-09-22 | Cedars-Sinai Medical Center | Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease |
CA2745849A1 (fr) * | 2008-12-09 | 2010-06-17 | Alethia Biotherapeutics Inc. | Nouveau variant retroviral endogene humain d'erv3 et utilisations de celui-ci pour diagnostiquer le cancer des ovaires |
JP2012523463A (ja) | 2009-04-13 | 2012-10-04 | ノースウエスタン ユニバーシティ | 軟骨再生のための新規なペプチドベースの足場およびその使用方法 |
WO2011028952A1 (fr) | 2009-09-02 | 2011-03-10 | Xencor, Inc. | Compositions et procédés pour une co-liaison bivalente et monovalente simultanée d'antigènes |
ES2802623T3 (es) * | 2010-01-27 | 2021-01-20 | Massachusetts Inst Technology | Agentes polipeptídicos técnicamente diseñados para la neutralización dirigida de amplio espectro de la gripe |
TW202344270A (zh) | 2010-09-29 | 2023-11-16 | 美商艾澤西公司 | 與191p4d12蛋白結合之抗體藥物共軛物(adc) |
KR101886029B1 (ko) | 2010-10-01 | 2018-08-07 | 호바 세라퓨틱스 에이피에스 | 무해자극통증, 통각과민증, 자발통증 및 헛통증의 치료를 위한 메테오린의 용도 |
DK2651430T3 (en) * | 2010-12-14 | 2018-08-27 | Hananja Ehf | Biological activity of placental protein 13 |
EP2753347B1 (fr) | 2011-09-05 | 2016-08-03 | NsGene A/S | Traitement de l'allodynie, de l'hyperalgie, de la douleur spontanée et de la douleur illusionnelle |
WO2013068445A1 (fr) * | 2011-11-09 | 2013-05-16 | Sanofi | Diacylglycérol lipase et applications associées |
CN104334573A (zh) | 2012-04-30 | 2015-02-04 | 比奥孔有限公司 | 靶向/免疫调节性融合蛋白及其制造方法 |
WO2013167153A1 (fr) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Anticorps utiles dans le diagnostic du cancer |
CN104470541A (zh) | 2012-05-14 | 2015-03-25 | 比奥根艾迪克Ma公司 | 用于治疗涉及运动神经元的疾患的lingo-2拮抗剂 |
WO2013174404A1 (fr) | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer |
RU2678127C2 (ru) | 2012-11-13 | 2019-01-23 | Бионтех Аг | Агенты для лечения экспрессирующих клаудин раковых заболеваний |
WO2014127785A1 (fr) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer |
US9023353B2 (en) | 2013-03-13 | 2015-05-05 | The Board Of Trustees Of The University Of Arkansas | Anti-(+)—methamphetamine monoclonal antibodies |
WO2014146672A1 (fr) | 2013-03-18 | 2014-09-25 | Ganymed Pharmaceuticals Ag | Thérapie comprenant des anticorps dirigés contre cldn 18.2 pour le traitement du cancer |
KR20210157418A (ko) | 2013-03-27 | 2021-12-28 | 세다르스-신나이 메디칼 센터 | Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한 섬유증 및 염증의 완화 및 반전 |
EP3971287A1 (fr) | 2013-07-11 | 2022-03-23 | ModernaTX, Inc. | Compositions comprenant des polynucléotides synthétiques codant pour des protéines liées à crispr et des arnsg synthétiques et méthodes d'utilisation |
EP4105236A1 (fr) | 2013-07-19 | 2022-12-21 | Cedars-Sinai Medical Center | Anticorps contre tl1a (tnfsf15) pour le traitement des maladies inflammatoires de l'intestin |
EP3049111A2 (fr) | 2013-09-25 | 2016-08-03 | Cytomx Therapeutics Inc. | Substrats pour métalloprotéinases matricielles et autres fragments clivables et leurs procédés d'utilisation |
JP6558699B2 (ja) | 2013-10-01 | 2019-08-14 | 国立大学法人三重大学 | 抗原提示を促進するエピトープ間配列を含むt細胞誘導ワクチン |
CA2937370A1 (fr) | 2014-01-31 | 2015-08-06 | Cytomx Therapeutics, Inc. | Substrats pour matriptase et activateur u-plasminogene et autres fractions clivables, et leurs procedes d'utilisation |
US10435467B2 (en) | 2015-01-08 | 2019-10-08 | Biogen Ma Inc. | LINGO-1 antagonists and uses for treatment of demyelinating disorders |
MA41374A (fr) | 2015-01-20 | 2017-11-28 | Cytomx Therapeutics Inc | Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci |
US11124766B2 (en) * | 2015-06-12 | 2021-09-21 | Emory University | Growth and survival compositions for cells capable of producing antibodies and methods related thereto |
PT3344776T (pt) | 2015-09-04 | 2021-08-03 | Synthetic Genomics Inc | Microorganismos recombinantes de algas com aumento de produtividade |
EP3430172A4 (fr) | 2016-03-17 | 2019-08-21 | Cedars-Sinai Medical Center | Méthode de diagnostic d'une maladie inflammatoire chronique de l'intestin par l'intermédiaire de rnase t2 |
WO2017172941A2 (fr) * | 2016-03-29 | 2017-10-05 | Berz David | Modulation de l'entretien structural de l'expression du chromosome-1 |
US9611297B1 (en) | 2016-08-26 | 2017-04-04 | Thrasos Therapeutics Inc. | Compositions and methods for the treatment of cast nephropathy and related conditions |
US11125757B2 (en) | 2017-05-26 | 2021-09-21 | Emory University | Methods of culturing and characterizing antibody secreting cells |
EP3508499A1 (fr) | 2018-01-08 | 2019-07-10 | iOmx Therapeutics AG | Anticorps ciblant et d'autres modulateurs d'un gène d'immunoglobuline associé à une résistance contre des réponses immunitaires antitumorales et leurs utilisations |
AU2020261435A1 (en) * | 2019-04-26 | 2021-11-25 | Sangamo Therapeutics, Inc. | Engineering AAV |
US20220372138A1 (en) | 2019-07-05 | 2022-11-24 | Iomx Therapeutics Ag | Antibodies binding igc2 of igsf11 (vsig3) and uses thereof |
WO2021083958A1 (fr) * | 2019-10-29 | 2021-05-06 | Specialites Pet Food | Nouveaux peptides induisant la satiété |
WO2021228999A1 (fr) * | 2020-05-12 | 2021-11-18 | Institut Curie | Épitopes néo-antigéniques associés à des mutations sf3b1 |
US20240010720A1 (en) | 2020-07-06 | 2024-01-11 | Iomx Therapeutics Ag | Antibodies binding igv of igsf11 (vsig3) and uses thereof |
CN117529492A (zh) * | 2021-01-21 | 2024-02-06 | 鹿特丹伊拉斯谟大学医疗中心 | 用于治疗的t细胞 |
JP2024509376A (ja) * | 2021-02-18 | 2024-03-01 | ベレン セラピューティクス ピー.ビー.シー. | 家族性ヘテロ接合型及びホモ接合型高コレステロール血症のシクロデキストリンによる治療方法 |
US20240158457A1 (en) * | 2022-05-20 | 2024-05-16 | Medikine, Inc. | Interleukin-18 receptor binding polypeptides and uses thereof |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4446240A (en) * | 1981-01-30 | 1984-05-01 | Nerenberg Samuel T | Pancreas specific protein systems |
US5457038A (en) * | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
US6080540A (en) * | 1990-04-20 | 2000-06-27 | Cold Spring Harbor Laboratory | Cloning of mammalian genes in microbial organisms and methods for pharmacological screening |
JP2845623B2 (ja) * | 1990-11-26 | 1999-01-13 | アメリカ合衆国 | 細胞のストレス転写因子 |
US5721352A (en) * | 1991-02-19 | 1998-02-24 | University Of Florida Research Foundation | Entomopoxvirus expression system |
US5840870A (en) * | 1995-12-29 | 1998-11-24 | Incyte Pharmaceuticals, Inc. | Polynucleotides PANC1A and PANC1B associated with pancreatic cancer |
WO1997007827A1 (fr) * | 1995-08-22 | 1997-03-06 | Thomas Jefferson University | Gab1, QUI EST UNE PROTEINE SE LIANT A Grb2, ET COMPOSITIONS POUR PRODUIRE ET UTILISER CETTE PROTEINE |
JP3462313B2 (ja) * | 1995-08-24 | 2003-11-05 | キッコーマン株式会社 | 変異型ウリカーゼ、変異型ウリカーゼ遺伝子、新規な組み換え体dna及び変異型ウリカーゼの製造法 |
US5998165A (en) * | 1995-12-29 | 1999-12-07 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a protein associated with pancreatic cancer |
JP2000511410A (ja) * | 1996-04-29 | 2000-09-05 | ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン | ナンセンス介在rna崩壊の哺乳動物の調節因子 |
US6500934B1 (en) * | 1996-07-24 | 2002-12-31 | Michael Rush Lerner | Bivalent agonists for G-protein coupled receptors |
US5976834A (en) * | 1997-01-09 | 1999-11-02 | Smithkline Beecham Corporation | cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor |
US5925521A (en) * | 1997-03-31 | 1999-07-20 | Incyte Pharmaceuticals, Inc. | Human serine carboxypeptidase |
CA2232743A1 (fr) * | 1997-04-02 | 1998-10-02 | Smithkline Beecham Corporation | Tl5, homologue tnf |
JP2001519666A (ja) * | 1997-04-10 | 2001-10-23 | ジェネティックス・インスチチュート・インコーポレーテッド | 分泌発現配列タグ(sESTs) |
IT1291110B1 (it) * | 1997-04-15 | 1998-12-29 | Istituto Europ Di Oncologia S | Interattori intracellulari e specificita' di legame del dominio eh |
US5948641A (en) * | 1997-05-29 | 1999-09-07 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a metal response element binding protein |
EP1012292A1 (fr) * | 1997-06-06 | 2000-06-28 | Regeneron Pharmaceuticals, Inc. | Element ntn-2 de la famille des ligands du tnf |
AU9484398A (en) * | 1997-09-17 | 1999-04-05 | Genentech Inc. | Promotion or inhibition of angiogenesis and cardiovascularization |
US5932442A (en) * | 1997-09-23 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Human regulatory molecules |
US5972660A (en) * | 1997-10-22 | 1999-10-26 | Incyte Pharmaceuticals, Inc. | Human hydroxypyruvate reductase |
DE19818598A1 (de) * | 1998-04-19 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Pankreasnormalgewebe |
NZ507728A (en) * | 1998-04-29 | 2002-06-28 | Genesis Res & Dev Corp Ltd | Information from a cDNA library created from keratinocytes, dermal papilla, neonatal foreskin fibroblast or embryonic skin cells is used to treating cancer, angiogenesis, skin inflammation, inflammatory diseases or stimulating keratinocyte growth |
US6262249B1 (en) * | 1998-06-23 | 2001-07-17 | Chiron Corporation | Pancreatic cancer genes |
CA2296792A1 (fr) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Sequences marqueurs exprimees et proteines humaines codees |
-
2001
- 2001-01-17 WO PCT/US2001/001340 patent/WO2001055321A2/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001324 patent/WO2001055314A2/fr active Search and Examination
- 2001-01-17 AU AU2001241408A patent/AU2001241408A1/en not_active Abandoned
- 2001-01-17 AU AU2001250770A patent/AU2001250770A1/en not_active Abandoned
- 2001-01-17 CA CA002395295A patent/CA2395295A1/fr not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001306 patent/WO2001055307A2/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001344 patent/WO2001055324A2/fr active Search and Examination
- 2001-01-17 AU AU2001241405A patent/AU2001241405A1/en not_active Abandoned
- 2001-01-17 CA CA002392422A patent/CA2392422A1/fr not_active Abandoned
- 2001-01-17 WO PCT/US2001/001341 patent/WO2001055322A2/fr active Search and Examination
- 2001-01-17 CA CA002392438A patent/CA2392438A1/fr not_active Abandoned
- 2001-01-17 WO PCT/US2001/001354 patent/WO2001057182A2/fr not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001335 patent/WO2001055319A2/fr active Search and Examination
- 2001-01-17 AU AU2001241414A patent/AU2001241414A1/en not_active Abandoned
- 2001-01-17 CA CA002393002A patent/CA2393002A1/fr not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001350 patent/WO2001055350A1/fr active Search and Examination
- 2001-01-17 CA CA002395666A patent/CA2395666A1/fr not_active Withdrawn
- 2001-01-17 AU AU2001241413A patent/AU2001241413A1/en not_active Abandoned
- 2001-01-17 AU AU2001241412A patent/AU2001241412A1/en not_active Abandoned
- 2001-01-17 CA CA002395398A patent/CA2395398A1/fr not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001338 patent/WO2001055367A1/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001312 patent/WO2001054733A1/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001328 patent/WO2001055316A2/fr active Search and Examination
- 2001-01-17 CA CA002397407A patent/CA2397407A1/fr not_active Withdrawn
- 2001-01-17 CA CA002393618A patent/CA2393618A1/fr not_active Abandoned
- 2001-01-17 AU AU2001241416A patent/AU2001241416A1/en not_active Abandoned
- 2001-01-17 AU AU2001241409A patent/AU2001241409A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001342 patent/WO2001059064A2/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001351 patent/WO2001055355A1/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001325 patent/WO2001055202A1/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001321 patent/WO2001055312A2/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001239 patent/WO2001055301A2/fr active Search and Examination
- 2001-01-17 CA CA002392751A patent/CA2392751A1/fr not_active Abandoned
- 2001-01-17 WO PCT/US2001/001301 patent/WO2001055303A2/fr not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001353 patent/WO2001055206A1/fr not_active Application Discontinuation
- 2001-01-17 AU AU2001241406A patent/AU2001241406A1/en not_active Abandoned
- 2001-01-17 CA CA002393912A patent/CA2393912A1/fr not_active Withdrawn
- 2001-01-17 CA CA002398877A patent/CA2398877A1/fr not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001358 patent/WO2001055163A1/fr not_active Application Discontinuation
- 2001-01-17 AU AU2001241418A patent/AU2001241418A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001337 patent/WO2001055205A1/fr active Search and Examination
- 2001-01-17 CA CA002395827A patent/CA2395827A1/fr not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001345 patent/WO2001055325A2/fr active Search and Examination
- 2001-01-17 CA CA002395671A patent/CA2395671A1/fr not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001309 patent/WO2001055308A2/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001349 patent/WO2001054474A2/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001352 patent/WO2001055327A2/fr not_active Application Discontinuation
- 2001-01-17 CA CA002395849A patent/CA2395849A1/fr active Pending
- 2001-01-17 CA CA002392428A patent/CA2392428A1/fr not_active Abandoned
- 2001-01-17 CA CA002395787A patent/CA2395787A1/fr not_active Withdrawn
- 2001-01-17 CA CA002392757A patent/CA2392757A1/fr not_active Abandoned
- 2001-01-17 WO PCT/US2001/001315 patent/WO2001055311A2/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001313 patent/WO2001055200A1/fr active Search and Examination
- 2001-01-17 CA CA002394841A patent/CA2394841A1/fr not_active Withdrawn
- 2001-01-17 AU AU2001241415A patent/AU2001241415A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001317 patent/WO2001055201A1/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001333 patent/WO2001055448A1/fr active Search and Examination
- 2001-01-17 CA CA002395816A patent/CA2395816A1/fr not_active Withdrawn
- 2001-01-17 CA CA002392450A patent/CA2392450A1/fr not_active Abandoned
- 2001-01-17 CA CA002395178A patent/CA2395178A1/fr not_active Withdrawn
- 2001-01-17 CA CA002395699A patent/CA2395699A1/fr active Pending
- 2001-01-17 WO PCT/US2001/001308 patent/WO2001055364A2/fr active Search and Examination
- 2001-01-17 CA CA002395872A patent/CA2395872A1/fr not_active Withdrawn
- 2001-01-17 CA CA002395654A patent/CA2395654A1/fr not_active Withdrawn
- 2001-01-17 AU AU2001241407A patent/AU2001241407A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001316 patent/WO2001054473A2/fr active Search and Examination
- 2001-01-17 CA CA002392398A patent/CA2392398A1/fr not_active Abandoned
- 2001-01-17 CA CA002397839A patent/CA2397839A1/fr not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001348 patent/WO2001055368A1/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001322 patent/WO2001055343A1/fr active Search and Examination
- 2001-01-17 CA CA002395734A patent/CA2395734A1/fr not_active Withdrawn
- 2001-01-17 AU AU2001241417A patent/AU2001241417A1/en not_active Abandoned
- 2001-01-17 CA CA002394039A patent/CA2394039A1/fr not_active Abandoned
- 2001-01-17 WO PCT/US2001/001240 patent/WO2001055302A2/fr not_active Application Discontinuation
- 2001-01-17 CA CA002393652A patent/CA2393652A1/fr not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001310 patent/WO2001055387A1/fr active Search and Examination
- 2001-01-17 CA CA002395724A patent/CA2395724A1/fr active Pending
- 2001-01-17 CA CA002395885A patent/CA2395885A1/fr not_active Withdrawn
- 2001-01-17 CA CA002398411A patent/CA2398411A1/fr not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001339 patent/WO2001055320A2/fr not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001330 patent/WO2001055447A1/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001343 patent/WO2001055323A2/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001336 patent/WO2001055204A1/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001359 patent/WO2001055328A2/fr active Application Filing
- 2001-01-17 CA CA002395729A patent/CA2395729A1/fr active Pending
- 2001-01-17 WO PCT/US2001/001356 patent/WO2001055173A2/fr not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001314 patent/WO2001055310A2/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001327 patent/WO2001055203A1/fr active Search and Examination
- 2001-01-17 CA CA002395693A patent/CA2395693A1/fr active Pending
- 2001-01-17 AU AU2001241410A patent/AU2001241410A1/en not_active Abandoned
- 2001-01-17 CA CA002395858A patent/CA2395858A1/fr not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001332 patent/WO2001055318A2/fr active Search and Examination
- 2001-01-17 CA CA002395738A patent/CA2395738A1/fr not_active Withdrawn
- 2001-01-17 CA CA002395403A patent/CA2395403A1/fr not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001357 patent/WO2001055208A1/fr not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001302 patent/WO2001055304A2/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001326 patent/WO2001055315A2/fr active Search and Examination
- 2001-01-17 WO PCT/US2001/001355 patent/WO2001055207A1/fr not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001311 patent/WO2001055309A2/fr active Search and Examination
- 2001-02-05 AU AU4313701A patent/AU4313701A/xx active Pending
- 2001-02-08 AU AU4141101A patent/AU4141101A/xx active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001055327A3 (fr) | Acides nucleiques, proteines et anticorps | |
WO2001055317A3 (fr) | Acides nucleiques, proteines et anticorps | |
WO2002000677A8 (fr) | Acides nucleiques, proteines et anticorps | |
WO2001059063A3 (fr) | Acides nucleiques, proteines et anticorps | |
WO2001055168A8 (fr) | Acides nucleiques, proteines, et anticorps | |
WO2001055300A8 (fr) | Acides nucleiques, proteines et anticorps | |
WO2001055167A8 (fr) | Acides nucleiques, proteines et anticorps | |
WO2001055313A8 (fr) | Acides nucleiques, proteines et anticorps | |
WO2001055162A8 (fr) | Acides nucleiques, proteines et anticorps | |
WO2001055329A8 (fr) | Acides nucleiques, proteines et anticorps |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 31/2001 UNDER "PUBLISHED", ADD "WITH SEQUENCE LISTING PART OF DESCRIPTION PUBLISHED SEPARATELY IN ELECTRONIC FORM AND AVAILABLE UPON REQUEST FROM THE INTERNATIONAL BUREAU." |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2392757 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001912662 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001912662 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001912662 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |